Is Bietti crystalline dystrophy gene therapy available in China?

Yes. ZVS101e gene therapy can be explored through the Boao Lecheng licensed medical-access pathway in Hainan. It is not currently available nationwide.

How much does Bietti crystalline dystrophy gene therapy cost in China?

The estimated cost is approximately US$64,600 (¥460,000) per eye. Patients should confirm final pricing and what the price covers directly with the hospital.

Who may qualify for ZVS101e gene therapy?

Patients with Bietti crystalline dystrophy involving a CYP4V2 mutation may be considered. Final eligibility requires assessment by the treating medical team.

Can international patients access Bietti crystalline dystrophy gene therapy in China?

International patients can explore access through the designated Boao Lecheng facilities, subject to medical evaluation, eligibility requirements, and the facility's licensed treatment arrangements.

top of page

ChinaCurelink
a MedeboundHEALTH Company

FREE CONSULTATION

ZVS101e Gene Therapy for Bietti Crystalline Dystrophy in China: 2026 International Patient Guide

ChinaCureLink

Mon Aug 31 2026

6 min read

Widget Didn’t Load

Check your internet and refresh this page.

If that doesn’t work, contact us.

bottom of page